Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique that could make it possible to fabricate medical implants in vivo and ...

High-risk NMIBC is characterised by poor prognosis, with half of patients recurring despite effective treatment with the ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing ...

It’s important to note that a myocardial infarction and a stroke, while both serious cardiovascular events, are not the same.

Q1 2025 Earnings Call Transcript May 12, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Welcome to the Relmada Therapeutics first-quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded, and will be available for replay on the location website ...

Research and development expenses for the first quarter of 2025 increased to $9.1 million from $7.7 million for the prior ...

A new ultrasound-guided 3D printing technique could make it possible to fabricate medical implants in vivo and deliver tailored therapies to tissues ...

ImmunityBio, Inc.’s IBRX share price has surged by 10.14%, which has investors questioning if this is right time to sell.

The Eufy E28 delivers predictably efficient results but the deep cleaning accessory will be the main draw for many buyers ...